Ono Pharmaceutical Co., Ltd. (OPHLY)
5.585
+0.02
(+0.37%)
USD |
OTCM |
Feb 23, 16:00
Ono Pharmaceutical EPS Diluted (Quarterly) : 0.1329 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1226 |
| AnGes, Inc. | -0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 187.50M |
| Revenue (Quarterly) | 908.03M |
| Total Expenses (Quarterly) | 720.70M |
| Enterprise Value | 7.494B |
| Gross Profit Margin (Quarterly) | 73.78% |
| Profit Margin (Quarterly) | 20.65% |
| Earnings Yield | 5.32% |